SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea
Closed for comments This consultation ended on at Request commenting lead permission
6 Implementation
NICE intends to develop tools, in association with relevant stakeholders, to help organisations put this guidance into practice.
In addition NICE will support this guidance through a range of activities to promote the recommendations for further research. The research proposed will be considered by the NICE Medical Technologies Evaluation Programme research facilitation team for developing specific research study protocols as appropriate. NICE will also incorporate the research recommendations in section 5 into its guidance research recommendations database and highlight these recommendations to public research bodies.
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions